Morocco Spends Over 6 Billion Dirhams on COVID-19 Vaccines, Leading Successful Pandemic Response

The bill for the purchase of vaccines has been hefty. In a context of global shortage, the Moroccan government has broken its piggy bank to ensure a good vaccination campaign and get the economy back on track, reports Hespress.

To achieve this, private partners, citizens and the state have combined their efforts to make Morocco one of the countries in the world that have best managed the Covid-19 crisis. In total, 34 billion dirhams have been mobilized, the site says, specifying that the expenses amounted to 29 billion dirhams in 2020.

This astronomical cost has mainly allowed the acquisition of Sinopharm, Astrazeneca, Johnson&Johnson, and Pfizer-BioNTech vaccines, by the crisis management committee set up to define and implement national strategies to fight the pandemic.

In addition to the vaccines, 3.2 billion dirhams were used to purchase medical equipment, drugs (especially chloroquine and hydroxychloroquine), pharmaceutical products and 6.079 billion dirhams for the purchase of vaccines.

The other expenses were devoted to the production of masks, the care of severe cases and support for families in precarious situations, the same source points out.